⌘K

Login Start Free

Home/Filings/4/0001209191-23-056987

4//SEC Filing

Tak Paul Peter 4

Accession 0001209191-23-056987

CIK 0001841387other

View on SEC.gov Company Profile

Filed

Nov 29, 7:00 PM ET

Accepted

Nov 30, 5:00 PM ET

Size

5.0 KB

Accession

0001209191-23-056987

Insider Transaction Report

Form 4

Period: 2023-11-28

Candel Therapeutics, Inc.CADL

DirectorChief Executive Officer

Transactions

Tax Payment
Common Stock
2023-11-28$0.90/sh−43,443$39,099→ 373,556 total

Footnotes (1)

[F1]These shares were withheld by the Issuer to satisfy tax withholding obligations associated with the vesting and settlement of restricted stock units.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Candel Therapeutics, Inc.

CIK 0001841387

Entity typeother

Related Parties

1

filerCIK 0001873905

Filing Metadata

Form type: 4
Filed: Nov 29, 7:00 PM ET
Accepted: Nov 30, 5:00 PM ET
Size: 5.0 KB

View on SEC.gov